Paris I Dysfibrinogenemia: A Point Mutation in Intron 8 Results in Insertion of a 15 Amino Acid Sequence in the Fibrinogen γ-Chain

Summary

Paris I dysfibrinogenemia results in the production of a fibrinogen molecule containing a functionally abnormal γ-chain. We determined the basis of the molecular defect using polymerase chain reaction (PCR) to amplify the γ-chain region of the Paris I subject’s genomic DNA. Comparative sequence analysis of cloned PCR segments of normal and Paris I genomic DNA revealed only an A→G point mutation occurring at nucleotide position 6588 within intron 8 of the Paris I γ-chain gene. We examined six normal individuals and found only normal sequence in this region, indicating that this change is not likely to represent a normal polymorphism. This nucleotide change leads to a 45 bp fragment being inserted between exons 8 and 9 in the mature γ_{paris I} chain mRNA, and encodes a 15 amino acid insert after γ350 [M-C-G-E-A-L-P-M-L-K-D-P-C-Y]. Alternative splicing of this region from intron 8 into the mature Paris I γ-chain mRNA also results after translation into a substitution of S for G at position γ351. Biochemical studies of ¹⁴C-iodoacetamide incorporation into disulfide-reduced Paris I and normal fibrinogen corroborated the molecular biologic predictions that two additional cysteine residues exist within the γ_{pariS I} chain. We conclude that the insertion of this amino acid sequence leads to a conformationallyaltered, and dysfunctional γ-chain in Paris I fibrinogen.

• References

• 1 Ménaché D. Constitutional and familial abnormal fibrinogen. Thromb Diath Haemorrh (Suppl) 1964; 13: 173-185
• 2 Guillin M-C, Ménaché D. Fetal fibrinogen and fibrinogen Paris I: Comparative fibrin monomers aggregation studies. Thromb Res 1973; 3: 117-135
• 3 Budzynski AZ, Marder VJ, Ménaché D, Guillin M-C. Defect in the gamma polypeptide chain of a congenital abnormal fibrinogen (Paris I). Nature (London) 1974; 252: 66-68
• 4 Mosesson MW, Amrani DL, Ménaché D. Studies on the structural abnormality of fibrinogen Paris I. J Clin Invest 1976; 57: 782-90
• 5 Mosesson MW, Denninger MH, Ménaché D. Hydrolysis of fibrinogen Paris I by plasmin. Thromb Res 1976; 9: 115-121
• 6 Stathakis NE, Mosesson MW, Galanakis DK, Ménaché D. Human fibrinogen heterogeneities. Preparation and characterization of γ and γ' chains. Thromb Res 1978; 13: 467-475
• 7 Chung DW, Davie EW. γ and γ' chains of human fibrinogen are produced by alternative mRNA processing. Biochemistry 1984; 23: 4232-4236
• 8 Fornace AJ, Cummings DE, Comeau CM, Kant JA, Crabtree GR. Structure of the human γ-fibrinogen gene: Alternate mRNA splicing near the 3' end of the gene produces γ_A and γ_B forms of γ-fibrinogen. J Biol Chem 1984; 259: 12826-12830
• 9 Denninger M-H, Jandrot-Perrus M, Elion J, Bertrand O, Homandberg GA, Mosesson MW, Guillin M-C. ADP-induced platelet aggregation depends on the conformation or availability of the terminal gamma chain sequence of fibrinogen. Study of the reactivity of fibrinogen Paris I. Blood 1987; 70: 558-563
• 10 Hymer WC, Kuff EL. Isolation of nuclei from mammalian tissues through the use of Triton X-100. J Histochem Cytochem 1964; 12: 359-363
• 11 Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuschi R, Horn GT, Mullis KG, Erlich HA. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487-491
• 12 Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press; Cold Spring Harbor, NY: 1982
• 13 Rixon MW, Chung DW, Davie EW. Nucleotide sequence of the gene for the γ-chain of human fibrinogen. Biochemistry 1985; 24: 2077-2086
• 14 Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci, USA 1977; 74: 5463-5467
• 15 Mount SM. A catalogue of splice junction sequences. Nucleic Acids Res 1982; 10: 459-472
• 16 Nienhuis AW, Anagnou NP, Ley TJ. Advances in Thalassemia research. Blood 1984; 63: 738-758
• 17 Treisman R, Orkin SH, Maniatis T. Specific Transcription and RNA splicing defects in five cloned β-Thalassemia genes. Nature 1983; 302: 591-596
• 18 Dilella AG, Marvit J, Lidsky AS, Guttler F, Woo SLC. Tight Linkage between a splicing mutation and a specific DNA haplotype in phenylketonuria. Nature 1986; 322: 799-803
• 19 Rees DJG, Rizza CR, Brownlee GG. Haemophilia B caused by a point mutation in a donor splice junction of the human factor IX gene. Nature 1985; 316: 643-645
• 20 Ohno K, Suzuki K. A splicing defect due to an exon-intron junctional mutation results in abnormal β-hexoaminidase α-chain mRNAs in Askenazi Jewish patients with Tay-Sachs disease. Biochem Biophys Res Commun 1988; 153: 463-469